issue

Aug 6, 2021

Volume 17 Number 5

This issue includes a European position paper on the management of patients with patent foramen ovale; also in hypertension and stroke, a novel left atrial appendage occluder, the Omega device. In coronary interventions: a mini focus on in-stent restenosis including articles on the increased risk for major adverse cardiovascular and cerebrovascular events in patients treated for in-stent restenosis; using optical coherence tomography before treating in-stent restenosis to evaluate neointimal patterns and clinical outcomes as well as possible differences in outcomes between drug-eluting stents and drug-coated balloons; quantitative flow ratio for functional assessment of in-stent restenosis. Also in coronary interventions: the efficacy of RUC-4, a second-generation, subcutaneous glycoprotein IIb/IIIa inhibitor for first-point-of-care treatment of STEMI; the SMART-DATE trial comparing biodegradable polymer biolimus-eluting stents and durable polymer everolimus- or zotarolimus-eluting stents in patients with acute coronary syndromes in relation to dual antiplatelet therapy duration; from the CULPRIT-SHOCK trial, studying critical culprit lesion location as having a predictive value in determining worse outcomes; the Glider balloon, for coronary bifurcation stenting; fusing computed tomography angiography with real-time fluoroscopy to provide real-time guidance in chronic total occlusion PCI; understanding the limitations and complications of coronary microcatheters from the Manufacturer and User Facility Device Experience (MAUDE) database; and more...

Viewpoint

Interventions for hypertension and stroke

European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions
Pristipino C, Germonpré P, Toni D, Sievert H, Meier B, D'Ascenzo F, Berti S, Onorato EM, Bedogni F, Mas J, Scacciatella P, Hildick-Smith D, Gaita F, Kyrle P, Thomson J, Derumeaux G, Sibbing D, Chessa M, Hornung M, Zamorano JL, Dudek D
10.4244/EIJ-D-20-00785
free
First-in-human results of the Omega left atrial appendage occluder for patients with non-valvular atrial fibrillation
Wilkins B, Srimahachota S, De Backer O, Boonyartavej S, Lertsuwunseri V, Tumkosit M, Søndergaard L
10.4244/EIJ-D-20-00552
free

Coronary Interventions - Mini Focus on Stent Restenosis

Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries
Tamez H, Secemsky E, Valsdottir L, Moussa I, Song Y, Simonton C, Gibson CM, Popma J, Yeh R
10.4244/EIJ-D-19-01031
free

Editorial comment

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis
Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, García-Guimaraes M, Lahmann A, Pinieck S, Rai H, Fusaro M, Schunkert H, Pérez-Vizcayno M, Gonzalo N, Alfonso F, Kastrati A
10.4244/EIJ-D-20-00662
free

Editorial comment

Quantitative flow ratio for functional evaluation of in-stent restenosis
Liontou C, Mejía-Rentería H, Lauri F, Goto S, Lee H, Nakayama M, Quiros A, Macaya F, Gonzalo N, Núñez-Gil I, Salinas P, Del Trigo M, Escaned J
10.4244/EIJ-D-18-00955
free
Optical coherence tomography and tailored treatment of in-stent restenosis
Jia H, Xu Y, Guagliumi G, Yu B
10.4244/EIJ-D-20-00507
free

Coronary interventions

Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction
Bor WL, Zheng K, Tavenier A, Gibson CM, Granger C, Bentur O, Lobatto R, Postma S, Coller B, van 't Hof AW, ten Berg JM
10.4244/EIJ-D-21-00287
free

Editorial comment

Culprit lesion location and outcomes in patients with multivessel disease and infarct-related cardiogenic shock: a core laboratory analysis of the CULPRIT-SHOCK trial
Hauguel-Moreau M, Barthélémy O, Farhan S, Huber K, Rouanet S, Zeitouni M, Guedeney P, Hage G, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G
10.4244/EIJ-D-20-00561
free
Feasibility and efficacy of an ultra-short side branch-dedicated balloon in coronary bifurcation stenting
Murasato Y, Nishihara M, Mori T, Meno K, Shibao K, Takenaka K, Iwasaki K
10.4244/EIJ-D-20-00334
free
Computed tomography angiography co-registration with real-time fluoroscopy in percutaneous coronary intervention for chronic total occlusions
Xenogiannis I, Jaffer F, Shah A, Omer M, Megaly M, Vemmou E, Nikolakopoulos I, Rangan B, Garcia S, Lesser JR, Cavalcante JL, Burke MN, Brilakis E
10.4244/EIJ-D-20-00175
free
Complications and failure modes of coronary microcatheters
Megaly M, Sedhom R, Pershad A, Vemmou E, Nikolakopoulos I, Karacsonyi J, Saad M, Mentias A, Garcia S, Karmpaliotis D, Egred M, Burke MN, Brilakis E
10.4244/EIJ-D-20-00572
free

Interventions for valvular disease and heart failure

Transcatheter tricuspid valve repair with the modified TriClip/MitraClip G4 system
Fam N, Ali F, Hassanin M, Ong G
10.4244/EIJ-D-20-01295
free
Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved